ak 2123 has been researched along with diethylnitrosamine in 1 studies
| Studies (ak 2123) | Trials (ak 2123) | Recent Studies (post-2010) (ak 2123) | Studies (diethylnitrosamine) | Trials (diethylnitrosamine) | Recent Studies (post-2010) (diethylnitrosamine) |
|---|---|---|---|---|---|
| 52 | 8 | 5 | 3,614 | 1 | 888 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alam, A; Rapthap, CC; Sharan, RN; Singh, V; Singha, LI | 1 |
1 other study(ies) available for ak 2123 and diethylnitrosamine
| Article | Year |
|---|---|
Radiomodulatory effect of liposome encapsulated AK-2123 on tumor in mice exposed to hepatocarcinogen.
Topics: Acetylcholinesterase; Animals; Carcinogens; Combined Modality Therapy; Diethylnitrosamine; DNA; Gamma Rays; gamma-Glutamyltransferase; Liposomes; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Radiation-Sensitizing Agents; RNA; Triazoles; Whole-Body Irradiation | 2005 |